Patents Assigned to sanotl-aventis
  • 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
    Patent number: 7001902
    Abstract: Compound corresponding to the general formula (I) in which R1, R2, R3, R4 and R5 each represent a hydrogen or halogen atom or a nitro, amino, trifluoromethyl, trifluoroalkoxy, cyano, hydroxyl, (C1–C6)alkyl or (C1–C6)alkoxy group and R6 represents a (C1–C6)alkyl group. Therapeutic application.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: February 21, 2006
    Assignee: sanotl-aventis
    Inventors: Thierry Gallet, Frédéric Galli, Odile Leclerc, Alistair Lochead